Dr. Tita is Professor of OBGYN and the Mary Heersink Endowed Chair of Global Health, and Director of the Mary Heersink Institute of Global Health at the University of Alabama at Birmingham (UAB). He is the Heersink School of Medicine Senior Associate Dean for Global and Women’s Health.

Dr. Tita directs the university-wide Center for Research in Women’s Health.  His background is in Maternal-Fetal Medicine, Perinatal Epidemiology and Global Health. Dr. Tita is dedicated to improving maternal and infant health outcomes and equity worldwide and has leveraged over $100M in funds. He co-leads the Cameroon Health Initiative, a multidisciplinary collaboration by UAB and Cameroon partners to improve health leveraging over $10M.

Dr. Tita has consulted for the World Health Organization, NIH (including serving NICHD National Advisory Council), CDC and the American Board of Obstetrics and Gynecology. He has co-authored over 400 publications and was elected into the National Academies of Medicine and to the Association of American Physicians.

Dr. Wallace is a native of Alabama. After completing a clinical fellowship in nephrology, Dr. Wallace joined the faculty at UAB where he has earned numerous accolades. 

Dr. Wallace became the Medical Director of Telehealth for UAB in January of 2017 given his work on telehealth for home dialysis in patients with Fabry disease. He received the Dean’s Excellence Award for Service in 2017 for his work in telehealth. Under his leadership, numerous outpatient telehealth programs have been initiated and scaled. These include telestroke which is now at 40 hospitals, tele-critical care at 12, and telenephrology at 7 hospitals. UAB continues to do at least 150000 telehealth visits a year. Dr. Wallace has also implemented remote patient monitoring and eConsult programs in Alabama. 

Dr. Wallace has won national awards for his work in telehealth including the American Society of Nephrology Mid-Career Award and Star Award from the National Organization of State Offices of Rural Health. It is his desire to use technology to help improve access to care disparities. 

Dr. Foma Munoh Kenne, MD, MPH, FACP, is a renowned internist specializing in hematology and medical oncology, currently spearheading Thoracic Oncology research at Presbyterian Hospital in Albuquerque, New Mexico.

With a Master’s in Public Health focused on clinical research and a background in clinical pathology from the University of Yaoundé I, Cameroon, Dr. Kenne blends exceptional patient care with a passion for medical education and transformative healthcare advocacy, particularly for Africa. His rigorous training includes residencies in clinical pathology and internal medicine, a fellowship in hematology and oncology at Richmond University Medical Center, New York—where he now teaches as an Assistant Professor of Oncology—and a commitment to mentoring future healthcare leaders.

A trailblazing advocate, he founded the Cameroon Town Hall for Healthcare Professionals in 2020, uniting over 5,000 experts worldwide, and collaborates with the Cameroon Ministry of Public Health to bolster healthcare systems. Honored with awards like the Guardian Angel Award and recognized for pioneering research in cancer, COVID-19, and sickle cell disease, Dr. Kenne drives innovations in cancer therapeutics, harnessing targeted therapies, immunotherapy, and precision medicine for better, personalized outcomes.

Prof. Wil Ngwa is Founding Director/PI of the Global Health Catalyst at Johns Hopkins, and Harvard. He leads development of transformative healthcare programs at the United States Advanced Research Project’s Agency for Health. He has served as Advisor of the White House on cancer and global health with over $400M in funding support for Africa, training thousands of oncology health professionals and the establishment of cancer centers in different African countries. 

His academic service includes serving as ICTU Distinguished Professor of Public Health, as Rutgers Presidential Fellow and Professor of Global Health and Radiation Oncology, as Guest Professor at University of Heidelberg Germany, and visiting Professor at the University of Pennsylvania. He is a co-founder of the Global Oncology University and Co-chair of Africa-Oxford-Harvard-Hopkins Clinical Trials Network.He has served as Chair of the Lancet Oncology Commission for sub-Saharan Africa, and currently co-leads the USA Moonshot 2.0 Lancet Oncology Commission. 

Wil has received over 45 prestigious awards/honors at Harvard, Johns Hopkins, international professional societies and other organizations for his leading efforts in global health, service and cancer research, including the U.S. Presidents Lifetime Achievement Award.

 Wil completed his graduate studies at the University of Leipzig Germany and completed his clinical training in Radiation Oncology at MD Anderson Cancer Center, and Harvard Medical School.

Dr. Bedimo is Professor of Medicine at the University of Texas Southwestern Medical Center (UTSW) and the Chief of Infectious Diseases at the VA North Texas. His research interests include the analysis of rates and mechanisms of chronic complications of HIV disease and antiretroviral therapy, as well as the contribution of HCV co-infection on HIV-associated morbidity.

Dr. Bedimo is also Interim Director of the UTSW Office of Global Health, a Clinical Research Site (CRS) leader for the AIDS Clinical Trials Group, and a member of the DHHS and IAS-USA HIV treatment guidelines panels. Finally, he’s the Editor in Chief of Open Forum Infectious Diseases and the Journal has a special focus on Planetary Health in Infectious Diseases.